MPYS, a Novel Membrane Tetraspanner, Is Associated with Major Histocompatibility Complex Class II and Mediates Transduction of Apoptotic Signals

REFERENCES

• Al-Daccak, R., N. Mooney, and D. Charron. 2004. MHC class II signaling in antigen-presenting cells. Curr. Opin. Immunol. 16:108–113.
   PubMedGoogle Scholar
• Bertho, N., V. M. Blancheteau, N. Setterblad, B. Laupeze, J. M. Lord, B. Drenou, L. Amiot, D. J. Charron, R. Fauchet, and N. Mooney. 2002. MHC class II-mediated apoptosis of mature dendritic cells proceeds by activation of the protein kinase C-delta isoenzyme. Int. Immunol. 14:935–942.
   PubMed Web of Science ®Google Scholar
• Bobbitt, K. R., and L. B. Justement. 2000. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22. J. Immunol. 165:5588–5596.
   PubMedGoogle Scholar
• Bridges, S. H., A. M. Kruisbeek, and D. L. Longo. 1987. Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma. J. Immunol. 139:4242–4249.
   PubMed Web of Science ®Google Scholar
• Brown, K. S., D. J. Levitt, M. Shannon, and B. K. Link. 2001. Phase II trial of Remitogen (humanized 1D10) monoclonal antibody targeting class II in patients with relapsed low-grade or follicular lymphoma. Clin. Lymphoma 2:188–190.
   PubMedGoogle Scholar
• Cambier, J. C., M. K. Newell, L. B. Justement, J. C. McGuire, K. L. Leach, and Z. Z. Chen. 1987. Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature 327:629–632.
   PubMed Web of Science ®Google Scholar
• Carlo-Stella, C., M. Di Nicola, M. C. Turco, L. Cleris, C. Lavazza, P. Longoni, M. Milanesi, M. Magni, M. Ammirante, A. Leone, Z. Nagy, W. R. Gioffre, F. Formelli, and A. M. Gianni. 2006. The anti-human leukocyte antigen-DR monoclonal antibody 1D09C3 activates the mitochondrial cell death pathway and exerts a potent antitumor activity in lymphoma-bearing nonobese diabetic/severe combined immunodeficient mice. Cancer Res. 66:1799–1808.
   PubMed Web of Science ®Google Scholar
• Carmagnat, M., B. Drenou, H. Chahal, J. M. Lord, D. Charron, J. Estaquier, and N. A. Mooney. 2006. Dissociation of caspase-mediated events and programmed cell death induced via HLA-DR in follicular lymphoma. Oncogene 25:1914–1921.
   PubMedGoogle Scholar
• Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160–1164.
   PubMed Web of Science ®Google Scholar
• Chen, Z. Z., K. M. Coggeshall, and J. C. Cambier. 1986. Translocation of protein kinase C during membrane immunoglobulin-mediated transmembrane signaling in B lymphocytes. J. Immunol. 136:2300–2304.
   PubMedGoogle Scholar
• Dal Porto, J. M., S. B. Gauld, K. T. Merrell, D. Mills, A. E. Pugh-Bernard, and J. Cambier. 2004. B cell antigen receptor signaling 101. Mol. Immunol. 41:599–613.
   PubMed Web of Science ®Google Scholar
• Drenou, B., L. Amiot, N. Setterblad, S. Taque, V. Guilloux, D. Charron, R. Fauchet, and N. Mooney. 2005. MHC class II signaling function is regulated during maturation of plasmacytoid dendritic cells. J. Leukoc. Biol. 77:560–567.
   PubMedGoogle Scholar
• Drenou, B., V. Blancheteau, D. H. Burgess, R. Fauchet, D. J. Charron, and N. A. Mooney. 1999. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J. Immunol. 163:4115–4124.
   PubMed Web of Science ®Google Scholar
• Guo, W., J. G. Castaigne, N. Mooney, D. Charron, and R. Al-Daccak. 2003. Signaling through HLA-DR induces PKC beta-dependent B cell death outside rafts. Eur. J. Immunol. 33:928–938.
   PubMedGoogle Scholar
• Ingulli, E., A. Mondino, A. Khoruts, and M. K. Jenkins. 1997. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J. Exp. Med. 185:2133–2141.
   PubMed Web of Science ®Google Scholar
• Jin, L., J. C. Stolpa, R. M. Young, A. E. Pugh-Bernard, Y. Refaeli, and J. C. Cambier. 2008. MHC class II structural requirements for the association with Igα/β, and signaling of calcium mobilization and cell death. Immunol. Lett. 116:184–194.
   PubMedGoogle Scholar
• Kim, K. J., F. I. Weinbaum, and R. Asofsky. 1978. Functional characteristics of BALB/c T cell lines: suppression in the mixed lymphocyte response and cell-mediated lysis. J. Immunol. 121:2299–2304.
   PubMedGoogle Scholar
• Lang, P., J. C. Stolpa, B. A. Freiberg, F. Crawford, J. Kappler, A. Kupfer, and J. C. Cambier. 2001. TCR-induced transmembrane signaling by peptide/MHC class II via associated Ig-alpha/beta dimers. Science 291:1537–1540.
   PubMedGoogle Scholar
• Leveille, C., R. Al-Daccak, and W. Mourad. 1999. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines. Eur. J. Immunol. 29:65–74.
   PubMed Web of Science ®Google Scholar
• Longo, D. L. 2002. DR's orders: human antibody kills tumors by direct signaling. Nat. Med. 8:781–783.
   PubMedGoogle Scholar
• Nagy, Z. A., B. Hubner, C. Lohning, R. Rauchenberger, S. Reiffert, E. Thomassen-Wolf, S. Zahn, S. Leyer, E. M. Schier, A. Zahradnik, C. Brunner, K. Lobenwein, B. Rattel, M. Stanglmaier, M. Hallek, M. Wing, S. Anderson, M. Dunn, T. Kretzschmar, and M. Tesar. 2002. Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells. Nat. Med. 8:801–807.
   PubMed Web of Science ®Google Scholar
• Nagy, Z. A., and N. A. Mooney. 2003. A novel, alternative pathway of apoptosis triggered through class II major histocompatibility complex molecules. J. Mol. Med. 81:757–765.
   PubMed Web of Science ®Google Scholar
• Newell, M. K., J. VanderWall, K. S. Beard, and J. H. Freed. 1993. Ligation of major histocompatibility complex class II molecules mediates apoptotic cell death in resting B lymphocytes. Proc. Natl. Acad. Sci. USA 90:10459–10463.
   PubMed Web of Science ®Google Scholar
• Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319–329.
   PubMed Web of Science ®Google Scholar
• Setterblad, N., V. Blancheteau, A. Delaguillaumie, F. Michel, S. Becart, G. Lombardi, O. Acuto, D. Charron, and N. Mooney. 2004. Cognate MHC-TCR interaction leads to apoptosis of antigen-presenting cells. J. Leukoc. Biol. 75:1036–1044.
   PubMedGoogle Scholar
• Tamir, I., J. C. Stolpa, C. D. Helgason, K. Nakamura, P. Bruhns, M. Daeron, and J. C. Cambier. 2000. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 12:347–358.
   PubMed Web of Science ®Google Scholar
• Truman, J. P., M. L. Ericson, C. J. Choqueux-Seebold, D. J. Charron, and N. A. Mooney. 1994. Lymphocyte programmed cell death is mediated via HLA class II DR. Int. Immunol. 6:887–896.
   PubMed Web of Science ®Google Scholar
• Ventura, A., A. Meissner, C. P. Dillon, M. McManus, P. A. Sharp, L. Van Parijs, R. Jaenisch, and T. Jacks. 2004. Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl. Acad. Sci. USA 101:10380–10385.
   PubMed Web of Science ®Google Scholar
• Vivier, E., and M. Daeron. 1997. Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 18:286–291.
   PubMedGoogle Scholar
• Wang, W., and B. A. Malcolm. 1999. Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QuikChange site-directed mutagenesis. BioTechniques 26:680–682.
   PubMed Web of Science ®Google Scholar
• Wille, L., M. L. Kemp, P. Sandy, C. L. Lewis, and D. A. Lauffenburger. 2007. Epi-allelic Erk1 and Erk2 knockdown series for quantitative analysis of T cell Erk regulation and IL-2 production. Mol. Immunol. 44:3085–3091.
   PubMedGoogle Scholar